[
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-07 12:27:24",
    "publisher": "Benzinga",
    "title": "Certain European Countries Order 40M Additional J&J COVID-19 Jabs: Reuters",
    "image": "https://images.financialmodelingprep.com/news/certain-european-countries-order-40m-additional-jj-covid19-jabs-20210707.jpg",
    "site": "benzinga.com",
    "text": "The European Union countries reportedly ordered nearly 40 million additional doses of the COVID-19 vaccine produced by Johnson & Johnson (NYSE: JNJ), a spokesman for the EU Commission said. EU nations initially ordered 200 million doses of the J&J vaccine and could buy up to another 200 million optional shots under the contract.",
    "url": "https://www.benzinga.com/general/biotech/21/07/21879891/certain-european-countries-order-40m-additional-j-j-covid-19-jabs-reuters",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-07T12:27:24-04:00",
    "date_et": "2021-07-07"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-08 07:31:05",
    "publisher": "Zacks Investment Research",
    "title": "Vaccine Stocks Fall as Delta Becomes Dominant Variant in US",
    "image": "https://images.financialmodelingprep.com/news/vaccine-stocks-fall-as-delta-becomes-dominant-variant-in-us-20210708.jpg",
    "site": "zacks.com",
    "text": "Per the latest CDC data, the Delta variant now makes up almost half of the COVID-19 cases in the United States.",
    "url": "https://www.zacks.com/stock/news/1758971/vaccine-stocks-fall-as-delta-becomes-dominant-variant-in-us",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-08T07:31:05-04:00",
    "date_et": "2021-07-08"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-08 12:48:00",
    "publisher": "Seeking Alpha",
    "title": "Dividend Income Summary: Bert's June 2021 Summary",
    "image": "https://images.financialmodelingprep.com/news/dividend-income-summary-berts-june-2021-summary-20210708.jpg",
    "site": "seekingalpha.com",
    "text": "Our stock screener continues to help us find some awesome undervalued dividend stocks to buy. In June, we received $2,341.62 in dividend income.",
    "url": "https://seekingalpha.com/article/4438334-dividend-income-summary-berts-june-2021-summary",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-08T12:48:00-04:00",
    "date_et": "2021-07-08"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-09 12:49:04",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Posts Positive 3-Year Stelara Data In Ulcerative Colitis",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-posts-positive-3year-stelara-data-in-ulcerative-20210709.jpeg",
    "site": "benzinga.com",
    "text": "The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) announced new three-year data from the long-term extension (LTE) of the Stelara (ustekinumab) Phase 3 UNIFI study. Investigators designed the trial to evaluate the safety and efficacy of induction and maintenance doses for the treatment in moderate to severely active ulcerative colitis patients.",
    "url": "https://www.benzinga.com/general/biotech/21/07/21918121/johnson-johnson-posts-positive-3-year-stelara-data-in-ulcerative-colitis",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-09T12:49:04-04:00",
    "date_et": "2021-07-09"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 09:09:54",
    "publisher": "Benzinga",
    "title": "Janssen's Darzalex Faspro Wins FDA Approval In Combination With Pomalidomide, Dexamethasone For Multiple Myeloma",
    "image": "https://images.financialmodelingprep.com/news/janssens-darzalex-faspro-wins-fda-approval-in-combination-with-20210712.jpg",
    "site": "benzinga.com",
    "text": "The FDA has approved Janssen Biotech Inc's, a unit of Johnson & Johnson (NYSE: JNJ) Darzalex Faspro (daratumumab and hyaluronidase-fihj) for multiple myeloma after first or subsequent relapse. Darzalex Faspro is co-formulated with recombinant human hyaluronidase PH20, Halozyme Therapeutics Inc's (NASDAQ: HALO) Enhanze drug delivery technology.",
    "url": "https://www.benzinga.com/general/biotech/21/07/21936109/janssens-darzalex-faspro-wins-fda-approval-in-combination-with-pomalidomide-dexamethasone-for-mul",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T09:09:54-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 13:12:15",
    "publisher": "Zacks Investment Research",
    "title": "Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-jnj-is-a-top-dividend-stock-for-20210712.jpg",
    "site": "zacks.com",
    "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?",
    "url": "https://www.zacks.com/stock/news/1760415/why-johnson-johnson-jnj-is-a-top-dividend-stock-for-your-portfolio",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T13:12:15-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 14:20:33",
    "publisher": "Business Insider",
    "title": "The FDA is reportedly planning to warn about a second rare side effect linked to Johnson & Johnson's coronavirus vaccine",
    "image": "https://images.financialmodelingprep.com/news/the-fda-is-reportedly-planning-to-warn-about-a-second-20210712.jpg",
    "site": "businessinsider.com",
    "text": "About 100 cases of a rare disorder have been reported in people who got the J&J shot, The Washington Post reported.",
    "url": "https://www.businessinsider.com/fda-guillain-barre-risk-for-johnson-and-johnson-covid-vaccine-2021-7",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T14:20:33-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 14:48:28",
    "publisher": "CNBC",
    "title": "FDA to announce new warning on J&J Covid vaccine related to a rare autoimmune disorder, report says",
    "image": "https://images.financialmodelingprep.com/news/fda-to-announce-new-warning-on-jj-covid-vaccine-20210712.jpeg",
    "site": "cnbc.com",
    "text": "The FDA is expected to announce a new warning for the J&J vaccine, saying the shot has been linked to a serious but rare autoimmune disorder.",
    "url": "https://www.cnbc.com/2021/07/12/fda-to-announce-new-warning-on-jj-covid-vaccine-related-to-a-rare-autoimmune-disorder-report-says.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T14:48:28-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 15:36:28",
    "publisher": "Market Watch",
    "title": "J&J's COVID-19 shot may be connected to rare autoimmune disorder: report",
    "image": "https://images.financialmodelingprep.com/news/jjs-covid19-shot-may-be-connected-to-rare-autoimmune-20210712.jpg",
    "site": "marketwatch.com",
    "text": "Shares of Johnson & Johnson were down 0.2% on Monday after The Washington Post reported that U.S. regulators plan to issue a new safety warning for the company's COVID-19 shot. The adenovirus viral vector, single-shot vaccine may be tied to rare instances of Guillain-Barré syndrome.",
    "url": "https://www.marketwatch.com/story/jjs-covid-19-shot-may-be-connected-to-rare-autoimmune-disorder-report-2021-07-12",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T15:36:28-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 15:38:41",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Vaccine Could Raise Risk For Rare Neurological Disorder, FDA To Warn",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-vaccine-could-raise-risk-for-rare-neurological-20210712.jpg",
    "site": "forbes.com",
    "text": "This is the latest setback for the J&J vaccine when it comes to U.S. regulators.",
    "url": "https://www.forbes.com/sites/nicholasreimann/2021/07/12/johnson--johnson-vaccine-could-raise-risk-for-rare-neurological-disorder-fda-to-warn/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T15:38:41-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-12 19:50:11",
    "publisher": "CNET",
    "title": "Johnson & Johnson vaccine linked to rare cases of autoimmune disorder",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-vaccine-linked-to-rare-cases-of-autoimmune-20210712.jpeg",
    "site": "cnet.com",
    "text": "The FDA issues a warning to Johnson & Johnson's COVID vaccine label about a rare risk of Guillain-Barré syndrome.",
    "url": "https://www.cnet.com/health/johnson-johnson-vaccine-linked-to-rare-cases-of-autoimmune-disorder/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-12T19:50:11-04:00",
    "date_et": "2021-07-12"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 05:06:00",
    "publisher": "The Motley Fool",
    "title": "COVID-19 Vaccines: How Much Revenue Will Each Drugmaker Generate in 2021?",
    "image": "https://images.financialmodelingprep.com/news/covid19-vaccines-how-much-revenue-will-each-drugmaker-generate-20210713.jpg",
    "site": "fool.com",
    "text": "Based on company forecasts, Wall Street estimates, and author guestimates, the top coronavirus vaccine developers will bring in billions of dollars in sales this year.",
    "url": "https://www.fool.com/investing/2021/07/13/covid-19-vaccines-how-much-revenue-in-2021/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T05:06:00-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 05:55:00",
    "publisher": "The Motley Fool",
    "title": "How Johnson & Johnson's COVID Vaccine Is Making a Comeback",
    "image": "https://images.financialmodelingprep.com/news/how-johnson-johnsons-covid-vaccine-is-making-a-comeback-20210713.jpg",
    "site": "fool.com",
    "text": "Things are finally looking up for the healthcare giant's COVID-19 vaccine.",
    "url": "https://www.fool.com/investing/2021/07/13/how-johnson-johnsons-covid-vaccine-is-making-a-com/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T05:55:00-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 06:21:31",
    "publisher": "Benzinga",
    "title": "FDA Adds Rare Nerve Condition As Second Warning To Johnson & Johnson's COVID-19 Vaccine",
    "image": "https://images.financialmodelingprep.com/news/fda-adds-rare-nerve-condition-as-second-warning-to-20210713.jpeg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson's (NYSE:JNJ) COVID-19 vaccine has been linked to a second rare but severe side effect. The FDA issued a warning that there are data \"connecting the shot to an increased risk\" of Guillain-Barré syndrome, a rare condition where the body's immune system attacks its nerves.",
    "url": "https://www.benzinga.com/general/biotech/21/07/21951216/fda-adds-rare-nerve-condition-as-second-warning-to-johnson-johnsons-covid-19-vaccine",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T06:21:31-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 07:46:23",
    "publisher": "CNBC",
    "title": "Fauci says he would be 'astounded' if Pfizer, Moderna and J&J Covid vaccines don't get full FDA approval",
    "image": "https://images.financialmodelingprep.com/news/fauci-says-he-would-be-astounded-if-pfizer-moderna-20210713.jpeg",
    "site": "cnbc.com",
    "text": "\"The data are about as good as it gets,\" Dr. Anthony Fauci told CNBC, saying he expects Pfizer, Moderna and J&J's vaccines to receive full FDA approval.",
    "url": "https://www.cnbc.com/2021/07/13/fauci-says-he-would-be-astounded-if-pfizer-moderna-and-jj-covid-vaccines-dont-get-full-fda-approval.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T07:46:23-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 09:17:31",
    "publisher": "CNBC",
    "title": "J&J, AstraZeneca explore modifying Covid vaccines in response to rare blood clot issue, report says",
    "image": "https://images.financialmodelingprep.com/news/jj-astrazeneca-explore-modifying-covid-vaccines-in-response-to-20210713.jpeg",
    "site": "cnbc.com",
    "text": "The blood clotting, which some scientists are now calling vaccine-induced immune thrombotic thrombocytopenia, or VITT, has been linked to both shots.",
    "url": "https://www.cnbc.com/2021/07/13/jj-astrazeneca-explore-modifying-covid-vaccines-in-response-to-rare-blood-clot-issue-report-says.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T09:17:31-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 12:10:30",
    "publisher": "Seeking Alpha",
    "title": "JCE: Discount Narrowing But Still Attractive, 7.26% Distribution After Boost Earlier In 2021",
    "image": "https://images.financialmodelingprep.com/news/jce-discount-narrowing-but-still-attractive-726-distribution-after-boost-20210713.jpg",
    "site": "seekingalpha.com",
    "text": "JCE: Discount Narrowing But Still Attractive, 7.26% Distribution After Boost Earlier In 2021",
    "url": "https://seekingalpha.com/article/4438982-jce-discount-narrowing-but-still-attractive-7-26-percent-distribution-after-boost-earlier-in-2021",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T12:10:30-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-13 19:28:20",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-stock-moves-012-what-you-should-20210713.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) closed at $169.27 in the latest trading session, marking a -0.12% move from the prior day.",
    "url": "https://www.zacks.com/stock/news/1761155/johnson-johnson-jnj-stock-moves-0-12-what-you-should-know",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-13T19:28:20-04:00",
    "date_et": "2021-07-13"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-14 09:25:39",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Ranked Among Today's Trending Stocks",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-ranked-among-todays-trending-stocks-20210714.jpg",
    "site": "forbes.com",
    "text": "Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified Johnson & Johnson among others.",
    "url": "https://www.forbes.com/sites/qai/2021/07/14/johnson--johnson-ranked-among-todays-trending-stocks/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-14T09:25:39-04:00",
    "date_et": "2021-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-14 09:35:00",
    "publisher": "Market Watch",
    "title": "The Margin: What are the symptoms of Guillain-Barré syndrome? Should I still get the J&J vaccine?",
    "image": "https://images.financialmodelingprep.com/news/the-margin-what-are-the-symptoms-of-guillainbarr-syndrome-20210714.jpg",
    "site": "marketwatch.com",
    "text": "What to know about Guillain-Barré syndrome and Johnson & Johnson's COVID-19 vaccine",
    "url": "https://www.marketwatch.com/story/what-are-the-symptoms-of-guillain-barre-syndrome-should-i-still-get-the-j-j-vaccine-11626269724",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-14T09:35:00-04:00",
    "date_et": "2021-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-14 10:07:15",
    "publisher": "InvestorPlace",
    "title": "7 Stocks to Buy if You're Worried About the Pandemic Like Warren Buffett",
    "image": "https://images.financialmodelingprep.com/news/7-stocks-to-buy-if-youre-worried-about-the-20210714.jpg",
    "site": "investorplace.com",
    "text": "With legendary investor Warren Buffett sounding worried about the pandemic, here are the stocks to buy to prepare yourself. The post 7 Stocks to Buy if You're Worried About the Pandemic Like Warren Buffett appeared first on InvestorPlace.",
    "url": "https://investorplace.com/2021/07/7-stocks-to-buy-if-worried-like-warren-buffett-about-pandemic/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-14T10:07:15-04:00",
    "date_et": "2021-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-14 13:55:14",
    "publisher": "Seeking Alpha",
    "title": "Our U.S. Stock Portfolio, First Half Of 2021 Review",
    "image": "https://images.financialmodelingprep.com/news/our-us-stock-portfolio-first-half-of-2021-review-20210714.jpg",
    "site": "seekingalpha.com",
    "text": "U.S. stocks moved to new all-time highs in the first half of 2021 as we eye the other side of the pandemic.",
    "url": "https://seekingalpha.com/article/4439213-our-us-stock-portfolio-first-half-of-2021-review",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-14T13:55:14-04:00",
    "date_et": "2021-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-14 16:09:25",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Reports Next Week: Wall Street Expects Earnings Growth",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-reports-next-week-wall-street-expects-earnings-20210714.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://www.zacks.com/stock/news/1761639/johnson-johnson-jnj-reports-next-week-wall-street-expects-earnings-growth",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-14T16:09:25-04:00",
    "date_et": "2021-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-14 17:00:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA® and AVEENO® Aerosol Sunscreen Products Due to the Presence of Benzene",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-consumer-inc-issues-voluntary-recall-of-specific-20210714.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., July 14, 2021 /PRNewswire/ -- Johnson & Johnson Consumer Inc. (JJCI) (NYSE: JNJ) is voluntarily recalling all lots of five NEUTROGENA® and AVEENO® aerosol sunscreen product lines to the consumer level.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-consumer-inc-issues-voluntary-recall-of-specific-neutrogena-and-aveeno-aerosol-sunscreen-products-due-to-the-presence-of-benzene-301334144.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-14T17:00:00-04:00",
    "date_et": "2021-07-14"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 00:35:51",
    "publisher": "CNN",
    "title": "Johnson and Johnson recalls some Neutrogena and Aveeno sunscreens after it detects benzene in them",
    "image": "https://images.financialmodelingprep.com/news/johnson-and-johnson-recalls-some-neutrogena-and-aveeno-sunscreens-20210715.jpg",
    "site": "cnn.com",
    "text": "Johnson & Johnson is issuing a voluntary recall for five Neutrogena and Aveeno sunscreen lines in the United States after it said it discovered low levels of benzene in the products.",
    "url": "https://www.cnn.com/2021/07/15/business/j-and-j-suncreen-recall-benzene/index.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T00:35:51-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 06:30:56",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Recalls Aveeno, Neutrogena Spray Sunscreens After Finding Benzene Traces",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-recalls-aveeno-neutrogena-spray-sunscreens-after-finding-20210715.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) said Wednesday that it is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure. The company said that consumers should stop using the products and discard them appropriately.",
    "url": "https://www.benzinga.com/news/21/07/21993165/johnson-johnson-recalls-aveeno-neutrogena-spray-sunscreens-after-finding-benzene-traces",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T06:30:56-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 07:15:29",
    "publisher": "New York Post",
    "title": "J&J recalls Aveeno, Neutrogena sunscreens over cancer-causing chemical",
    "image": "https://images.financialmodelingprep.com/news/jj-recalls-aveeno-neutrogena-sunscreens-over-cancercausing-chemical-20210715.jpg",
    "site": "nypost.com",
    "text": "Johnson & Johnson is recalling five of its Neutrogena and Aveeno spray sunscreens after the company found low levels of benzene, a cancer-causing chemical, in some samples.",
    "url": "https://nypost.com/2021/07/15/jj-recalls-aveeno-neutrogena-sunscreens-over-cancer-risk/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T07:15:29-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 08:00:00",
    "publisher": "Seeking Alpha",
    "title": "Where Will Johnson & Johnson Stock Be In 5 Years?",
    "image": "https://images.financialmodelingprep.com/news/where-will-johnson-johnson-stock-be-in-5-years-20210715.jpg",
    "site": "seekingalpha.com",
    "text": "Where Will Johnson & Johnson Stock Be In 5 Years?",
    "url": "https://seekingalpha.com/article/4439210-johnson-johnson-stock-price-5-years",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T08:00:00-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 09:19:12",
    "publisher": "Zacks Investment Research",
    "title": "J&J (JNJ) Recalls Some Sunscreens Due to Benzene Presence",
    "image": "https://images.financialmodelingprep.com/news/jj-jnj-recalls-some-sunscreens-due-to-benzene-presence-20210715.jpg",
    "site": "zacks.com",
    "text": "J&J (JNJ) withdraws five aerosol sunscreen products from the market due to \"low levels\" of benzene found in some samples.",
    "url": "https://www.zacks.com/stock/news/1761928/j-j-jnj-recalls-some-sunscreens-due-to-benzene-presence",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T09:19:12-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 11:52:00",
    "publisher": "Barron's",
    "title": "Johnson & Johnson Is Recalling Sunscreen. Now the Stock Is Down.",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-is-recalling-sunscreen-now-the-stock-is-20210715.jpg",
    "site": "barrons.com",
    "text": "The stock wasn't much affected by the news of some rare cases of a neurological disorder after the vaccine, but shares are down after a sunscreen recall.",
    "url": "https://www.barrons.com/articles/johnson-johnson-is-recalling-sunscreen-now-the-stock-is-down-51626364334",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T11:52:00-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 13:32:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Faces Class-Action Lawsuit Over Benzene-Tainted Neutrogena and Aveeno Sunscreen Products",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-faces-classaction-lawsuit-over-benzenetainted-neutrogena-and-20210715.jpg",
    "site": "prnewswire.com",
    "text": "SAN FRANCISCO, July 15, 2021 /PRNewswire/ -- Pharmaceutical product-safety lawyers at the Beasley Allen law firm have filed a federal class-action lawsuit on behalf of consumers who bought recalled benzene-tainted sunscreen products made by Johnson & Johnson (NYSE: JNJ) subsidiaries Neutrogena and Aveeno. The lawsuit seeks an injunction and damages on behalf of consumers who purchased a range of Neutrogena and Aveeno sun-care products.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-faces-class-action-lawsuit-over-benzene-tainted-neutrogena-and-aveeno-sunscreen-products-301335040.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T13:32:00-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 14:51:57",
    "publisher": "New York Post",
    "title": "J&J sued after recalling sunscreens due to cancer-causing chemical",
    "image": "https://images.financialmodelingprep.com/news/jj-sued-after-recalling-sunscreens-due-to-cancercausing-chemical-20210715.jpg",
    "site": "nypost.com",
    "text": "J&J has been slapped with a lawsuit after the pharmaceutical giant announced Wednesday that it was recalling five of its spray sunscreens.",
    "url": "https://nypost.com/2021/07/15/jj-sued-after-recalling-sunscreens-due-to-cancer-causing-chemical/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T14:51:57-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-15 19:33:18",
    "publisher": "Forbes",
    "title": "CVS Halts Sales Of Two Sun-Care Products Following J&J Sunscreen Recall",
    "image": "https://images.financialmodelingprep.com/news/cvs-halts-sales-of-two-suncare-products-following-jj-20210715.jpg",
    "site": "forbes.com",
    "text": "The pause comes as the products were found to have contained the same carcinogen as the J&J recalled sunscreens through independent testing in May.",
    "url": "https://www.forbes.com/sites/kimberleespeakman/2021/07/15/cvs-halts-sales-of-two-sun-care-products-following-jj-sunscreen-recall/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-15T19:33:18-04:00",
    "date_et": "2021-07-15"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-16 19:14:40",
    "publisher": "Zacks Investment Research",
    "title": "Q2 Earnings Reports Confirm Economic Boom Ahead",
    "image": "https://images.financialmodelingprep.com/news/q2-earnings-reports-confirm-economic-boom-ahead-20210716.jpg",
    "site": "zacks.com",
    "text": "We are off to a great start in the Q2 earnings season, with 2021 Q2 earnings projected to climb 14.5% above the comparable pre-Covid 2019 period.",
    "url": "https://www.zacks.com/commentary/1763030/q2-earnings-reports-confirm-economic-boom-ahead",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-16T19:14:40-04:00",
    "date_et": "2021-07-16"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-17 06:01:00",
    "publisher": "The Motley Fool",
    "title": "Could Johnson & Johnson's COVID Vaccine Make a Comeback Because of the Delta Variant?",
    "image": "https://images.financialmodelingprep.com/news/could-johnson-johnsons-covid-vaccine-make-a-comeback-because-20210717.jpg",
    "site": "fool.com",
    "text": "Maybe, but probably not very much in the U.S.",
    "url": "https://www.fool.com/investing/2021/07/17/could-johnson-johnsons-covid-vaccine-make-a-comeba/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-17T06:01:00-04:00",
    "date_et": "2021-07-17"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-18 05:52:00",
    "publisher": "The Motley Fool",
    "title": "3 Dividend Stocks to Buy and Hold Forever",
    "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-to-buy-and-hold-forever-20210718.jpg",
    "site": "fool.com",
    "text": "Each of these stocks has a business model that's built to last.",
    "url": "https://www.fool.com/investing/2021/07/18/3-dividend-stocks-to-buy-and-hold-forever/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-18T05:52:00-04:00",
    "date_et": "2021-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-18 09:18:00",
    "publisher": "The Motley Fool",
    "title": "2 Top Pharma Stocks to Buy Right Now",
    "image": "https://images.financialmodelingprep.com/news/2-top-pharma-stocks-to-buy-right-now-20210718.jpg",
    "site": "fool.com",
    "text": "The market may be underappreciating the long-term prospects of Johnson & Johnson and Merck.",
    "url": "https://www.fool.com/investing/2021/07/18/2-top-pharma-stocks-to-buy-right-now/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-18T09:18:00-04:00",
    "date_et": "2021-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-18 15:16:00",
    "publisher": "Reuters",
    "title": "Exclusive: J&J exploring putting talc liabilities into bankruptcy, sources say",
    "image": "https://images.financialmodelingprep.com/news/exclusive-jj-exploring-putting-talc-liabilities-into-bankruptcy-sources-20210718.jpg",
    "site": "reuters.com",
    "text": "Johnson & Johnson is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection, according to seven people familiar with the matter.",
    "url": "https://www.reuters.com/article/us-johnson-johnson-talc-exclusive/exclusive-jj-exploring-putting-talc-liabilities-into-bankruptcy-sources-say-idUSKBN2EO0KA",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-18T15:16:00-04:00",
    "date_et": "2021-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-18 21:18:00",
    "publisher": "PRNewsWire",
    "title": "Lawyers for Ovarian Cancer Victims Call on Regulators to Stop 'Contemptible' Johnson & Johnson Bankruptcy Plan",
    "image": "https://images.financialmodelingprep.com/news/lawyers-for-ovarian-cancer-victims-call-on-regulators-to-20210718.jpg",
    "site": "prnewswire.com",
    "text": "MONTGOMERY, Ala., July 18, 2021 /PRNewswire/ -- Attorneys representing several thousand women diagnosed with ovarian cancer after exposure to Johnson & Johnson (NYSE: JNJ) Baby Powder and other talc-based products are denouncing the company over reports it is considering bankruptcy to avoid financial responsibility.",
    "url": "https://www.prnewswire.com/news-releases/lawyers-for-ovarian-cancer-victims-call-on-regulators-to-stop-contemptible-johnson--johnson-bankruptcy-plan-301336142.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-18T21:18:00-04:00",
    "date_et": "2021-07-18"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 05:07:14",
    "publisher": "Seeking Alpha",
    "title": "Week 29 MDA Breakout Stocks - July 2021: Short-Term Stocks And Funds To Give You An Edge",
    "image": "https://images.financialmodelingprep.com/news/week-29-mda-breakout-stocks-july-2021-shortterm-stocks-20210719.jpg",
    "site": "seekingalpha.com",
    "text": "Two new sample breakout stocks for Week 29 with better than 10% short-term upside potential. New ETF/ETN forecast section has been added. This past week the peak gains were in ATOS +26.6% and FUV +5.8% with Market and S&P 500 Momentum Gauges in extremely high negative warning conditions.",
    "url": "https://seekingalpha.com/article/4439832-week-29-mda-breakout-stocks-july-2021-short-term-stocks-and-funds-to-give-you-an-edge",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T05:07:14-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 09:13:09",
    "publisher": "Zacks Investment Research",
    "title": "5 Best Inverse/Leveraged ETF Areas of Last Week",
    "image": "https://images.financialmodelingprep.com/news/5-best-inverseleveraged-etf-areas-of-last-week-20210719.jpg",
    "site": "zacks.com",
    "text": "Wall Street was subdued last week. A slew of earnings results for the second quarter and a new report on consumer spending for June came in stronger than expected.",
    "url": "https://www.zacks.com/stock/news/1763258/5-best-inverse-leveraged-etf-areas-of-last-week",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T09:13:09-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 11:28:21",
    "publisher": "Zacks Investment Research",
    "title": "Will J&J (JNJ) Initiate Pharma Q2 Earnings With a Beat?",
    "image": "https://images.financialmodelingprep.com/news/will-jj-jnj-initiate-pharma-q2-earnings-with-a-beat-20210719.jpg",
    "site": "zacks.com",
    "text": "J&J's (JNJ) Pharma segment is expected to have performed above market. Market recovery might have led to continued recovery in Medical Devices segment in the second quarter.",
    "url": "https://www.zacks.com/stock/news/1763531/will-j-j-jnj-initiate-pharma-q2-earnings-with-a-beat",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T11:28:21-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 12:11:12",
    "publisher": "24/7 Wall Street",
    "title": "Earnings Previews: ASML, Coca-Cola, Harley-Davidson, Johnson & Johnson, Verizon",
    "image": "https://images.financialmodelingprep.com/news/earnings-previews-asml-cocacola-harleydavidson-johnson-johnson-verizon-20210719.jpg",
    "site": "247wallst.com",
    "text": "With the first week of the June-quarter earnings season behind us, we are looking ahead to what the coming week has in store.",
    "url": "https://247wallst.com/investing/2021/07/19/earnings-previews-asml-coca-cola-harley-davidson-johnson-johnson-verizon/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T12:11:12-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 12:13:30",
    "publisher": "Zacks Investment Research",
    "title": "Fears of a Covid Resurgence Weigh on Equity Prices",
    "image": "https://images.financialmodelingprep.com/news/fears-of-a-covid-resurgence-weigh-on-equity-prices-20210719.jpg",
    "site": "zacks.com",
    "text": "With 40% of Americans still unvaccinated, an outbreak of delta-variant infections threatens the economic recovery.",
    "url": "https://www.zacks.com/commentary/1763470/fears-of-a-covid-resurgence-weigh-on-equity-prices",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T12:13:30-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 12:13:31",
    "publisher": "Zacks Investment Research",
    "title": "Delta Variant Rattles Monday Pre-Market",
    "image": "https://images.financialmodelingprep.com/news/delta-variant-rattles-monday-premarket-20210719.jpg",
    "site": "zacks.com",
    "text": "We're following last week's lower trading with a big drop: the Dow -475 points, the S&P 500 -50 and the Nasdaq -125.",
    "url": "https://www.zacks.com/stock/news/1763511/delta-variant-rattles-monday-pre-market",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T12:13:31-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 12:17:08",
    "publisher": "New York Post",
    "title": "J&J weighs putting talc liabilities into bankruptcy amid lawsuits",
    "image": "https://images.financialmodelingprep.com/news/jj-weighs-putting-talc-liabilities-into-bankruptcy-amid-lawsuits-20210719.jpg",
    "site": "nypost.com",
    "text": "Johnson & Johnson is weighing whether to spin off liabilities from the lawsuits brought against it over the company's iconic baby powder into a new business that would then seek bankruptcy protection.",
    "url": "https://nypost.com/2021/07/19/jj-weighs-putting-talc-liabilities-into-bankruptcy/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T12:17:08-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 12:35:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2021-20210719.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., July 19, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2021 of $1.06 per share on the company's common stock.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-announces-quarterly-dividend-for-third-quarter-2021-301336582.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T12:35:00-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-19 22:36:00",
    "publisher": "Reuters",
    "title": "U.S. states to unveil $26 billion opioid settlement with drug distributors, J&J - sources",
    "image": "https://images.financialmodelingprep.com/news/us-states-to-unveil-26-billion-opioid-settlement-with-20210719.jpg",
    "site": "reuters.com",
    "text": "(Reuters) -U.S. state attorneys general are expected this week to unveil a $26 billion settlement resolving claims that three major drug distributors and drugmaker Johnson & Johnson helped fuel a nationwide opioid epidemic, people familiar with the matter said on Monday.",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/drug-distributors-jj-announce-26-bln-opioid-settlement-this-week-source-2021-07-19/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-19T22:36:00-04:00",
    "date_et": "2021-07-19"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-20 07:11:00",
    "publisher": "The Motley Fool",
    "title": "Have $1,000? 2 Stocks to Buy Before the Next Market Crash",
    "image": "https://images.financialmodelingprep.com/news/have-1000-2-stocks-to-buy-before-the-next-20210720.jpg",
    "site": "fool.com",
    "text": "Don't let rumors of another market downturn stop you from investing in more top stocks.",
    "url": "https://www.fool.com/investing/2021/07/20/have-1000-2-stocks-to-buy-before-the-next-market-c/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-20T07:11:00-04:00",
    "date_et": "2021-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-20 15:00:32",
    "publisher": "Investopedia",
    "title": "Johnson & Johnson (JNJ) Option Traders Ready for Positive Earnings",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-option-traders-ready-for-positive-earnings-20210720.jpg",
    "site": "investopedia.com",
    "text": "A noticeable collection of put options remain in the open interest for JNJ and appear to be initiated as sell orders.",
    "url": "https://www.investopedia.com/jnj-option-traders-ready-for-positive-earnings-5193423",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-20T15:00:32-04:00",
    "date_et": "2021-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-20 19:34:43",
    "publisher": "Forbes",
    "title": "Johnson & Johnson Vaccine Far Less Effective Against Delta Variant, Study Suggests",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-vaccine-far-less-effective-against-delta-variant-20210720.jpg",
    "site": "forbes.com",
    "text": "More than 13 million Americans have received the J&J vaccine.",
    "url": "https://www.forbes.com/sites/nicholasreimann/2021/07/20/johnson--johnson-vaccine-far-less-effective-against-delta-variant-study-suggests/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-20T19:34:43-04:00",
    "date_et": "2021-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-20 20:39:13",
    "publisher": "CNBC",
    "title": "Dr. Vin Gupta encourages J&J vaccine recipients to get a Pfizer or Moderna booster",
    "image": "https://images.financialmodelingprep.com/news/dr-vin-gupta-encourages-jj-vaccine-recipients-to-get-20210720.jpeg",
    "site": "cnbc.com",
    "text": "Dr. Vin Gupta explains why he's encouraging patients who received the single-shot J&J Covid vaccine to get a Pfizer or Moderna booster shot.",
    "url": "https://www.cnbc.com/2021/07/20/dr-vin-gupta-encourages-jj-vaccine-recipients-to-get-a-pfizer-or-moderna-booster.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-20T20:39:13-04:00",
    "date_et": "2021-07-20"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 02:10:00",
    "publisher": "Market Watch",
    "title": "The New York Post: Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says study",
    "image": "https://images.financialmodelingprep.com/news/the-new-york-post-johnson-johnson-covid19-vaccine-may-20210721.jpg",
    "site": "marketwatch.com",
    "text": "The study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may need to receive a second shot as the variant continues to spread across the US.",
    "url": "https://www.marketwatch.com/story/johnson-johnson-covid-19-vaccine-may-not-perform-as-well-against-delta-variant-says-study-11626847811",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T02:10:00-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 06:25:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson Reports Q2 2021 Results",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-reports-q2-2021-results-20210721.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., July 21, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-reports-q2-2021-results-301338422.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T06:25:00-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 06:30:59",
    "publisher": "Market Watch",
    "title": "Coronavirus tally: Global cases of COVID-19 top 191.4 million and study finds J&J vaccine less effective vs. delta variant",
    "image": "https://images.financialmodelingprep.com/news/coronavirus-tally-global-cases-of-covid19-top-1914-million-20210721.jpg",
    "site": "marketwatch.com",
    "text": "The global tally for the coronavirus-borne illness climbed above 191.4 million on Wednesday, while the death toll climbed above 4.1 million, according to data aggregated by Johns Hopkins University. The U.S. leads the world with a total of 34 million cases and in deaths with 609,529 as the highly infectious delta variant continues to spread fast, especially in states with low vaccination rates.",
    "url": "https://www.marketwatch.com/story/coronavirus-tally-global-cases-of-covid-19-top-1914-million-and-study-finds-jj-vaccine-less-effective-vs-delta-variant-2021-07-21",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T06:30:59-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 06:43:00",
    "publisher": "Reuters",
    "title": "Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-forecasts-25-billion-in-covid19-vaccine-sales-20210721.jpg",
    "site": "reuters.com",
    "text": "(Reuters) -Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with vaccine production issues and safety concerns.",
    "url": "https://www.reuters.com/article/us-johnson-johnson-results/johnson-johnson-forecasts-2-5-billion-in-covid-19-vaccine-sales-this-year-idUSKBN2ER10F",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T06:43:00-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 06:45:49",
    "publisher": "Market Watch",
    "title": "Johnson & Johnson beats earnings estimates for Q2 and raises full-year guidance",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-beats-earnings-estimates-for-q2-and-raises-fullyear-20210721.jpg",
    "site": "marketwatch.com",
    "text": "Johnson & Johnson shares rose 1.1% in premarket trade Wednesday, after the consumer and health company beat earnings estimates for the second quarter and raised its full-year guidance. The company said it had net income of $6.278 billion, or $2.35 a share, up from $3.626 billion, or $1.36 a share, in the year-earlier period.",
    "url": "https://www.marketwatch.com/story/johnson-johnson-beats-earnings-estimates-for-q2-and-raises-full-year-guidance-2021-07-21",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T06:45:49-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 07:10:50",
    "publisher": "CNBC",
    "title": "Johnson & Johnson expects $2.5 billion in global sales from Covid vaccine this year",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-expects-25-billion-in-global-sales-from-20210721.jpeg",
    "site": "cnbc.com",
    "text": "Global sales of the Covid vaccine in the quarter were $164 million.",
    "url": "https://www.cnbc.com/2021/07/21/johnson-johnson-jnj-earnings-q2-2021.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T07:10:50-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 07:26:46",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Q2 Earnings Beat Expectations; Raises FY21 Outlook, Sees $2.5B Sales From COVID Vaccine",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-q2-earnings-beat-expectations-raises-fy21-outlook-20210721.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) reported Q2 adjusted earnings of $2.48 per share, almost 50% higher than the $1.67 posted a year ago and better than the consensus of $2.27. Net sales increased 27% Y/Y to $23.3 billion, and ahead of the $22.1 billion consensus.",
    "url": "https://www.benzinga.com/general/biotech/21/07/22078754/johnson-johnson-q2-earnings-beat-expectations-raises-fy21-outlook-sees-2-5b-sales-from-covid-vacc",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T07:26:46-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 09:19:16",
    "publisher": "Zacks Investment Research",
    "title": "Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-q2-earnings-and-revenues-top-estimates-20210721.jpg",
    "site": "zacks.com",
    "text": "Johnson & Johnson (JNJ) delivered earnings and revenue surprises of 8.77% and 4.50%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://www.zacks.com/stock/news/1764794/johnson-johnson-jnj-q2-earnings-and-revenues-top-estimates",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T09:19:16-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 09:24:46",
    "publisher": "New York Post",
    "title": "J&J forecasts $2.5B COVID vaccine sales this year, lagging rivals",
    "image": "https://images.financialmodelingprep.com/news/jj-forecasts-25b-covid-vaccine-sales-this-year-lagging-20210721.jpg",
    "site": "nypost.com",
    "text": "Johnson & Johnson revealed that it expects to take home about $2.5 billion from COVID-19 vaccine sales in 2021, far lower than estimates from its jab rivals Moderna and Pfizer.",
    "url": "https://nypost.com/2021/07/21/jj-forecasts-2-5b-from-covid-19-vaccine-sales-this-year/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T09:24:46-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 10:12:19",
    "publisher": "Benzinga",
    "title": "Earnings Strength From J&J, Chipotle, Coca-Cola Helps Set Positive Early Tone",
    "image": "https://images.financialmodelingprep.com/news/earnings-strength-from-jj-chipotle-cocacola-helps-set-positive-20210721.jpg",
    "site": "benzinga.com",
    "text": "The earnings parade continues, with a steady flow of solid corporate results helping Wall Street recover from Monday's huge plunge. In fact, the major indices are basically back where they were Friday after two crazy days, making it look like Monday and Tuesday never happened.",
    "url": "https://www.benzinga.com/news/earnings/21/07/22083759/earnings-strength-from-j-j-chipotle-coca-cola-helps-set-positive-early-tone",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T10:12:19-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 11:27:04",
    "publisher": "PYMNTS",
    "title": "Johnson & Johnson Q2 Growth Driven By Consumer Products, Medical Devices",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-q2-growth-driven-by-consumer-products-medical-20210721.jpg",
    "site": "pymnts.com",
    "text": "Johnson & Johnson posted strong second-quarter results on Tuesday (July 21), beating Wall Street estimates as sales of beauty and skincare products begin to recover from COVID-19 and patients resume previously deferred medical procedures. The New Jersey-based company reported over $23 billion in sales for the three months ending June 30, a 27 percent year-over-year […]",
    "url": "https://www.pymnts.com/news/retail/2021/johnson-johnson-q2-growth-driven-by-consumer-products-medical-devices/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T11:27:04-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 12:58:03",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson (JNJ) on Q2 2021 Results - Earnings Call Transcript",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-on-q2-2021-results-earnings-call-20210721.jpg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson (JNJ) on Q2 2021 Results - Earnings Call Transcript",
    "url": "https://seekingalpha.com/article/4440406-johnson-and-johnson-jnj-on-q2-2021-results-earnings-call-transcript",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T12:58:03-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 13:58:12",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson's COVID-19 Shot Is Less Effective Against Delta Variant: Study",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnsons-covid19-shot-is-less-effective-against-delta-20210721.jpg",
    "site": "benzinga.com",
    "text": "As the Delta variant rapidly spreads across the U.S., accounting for 83% of the country's cases, a new study showed that neutralizing titers induced by Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine decreased 5.4-fold against the Delta plus variant. What Happened: In comparison, titers induced by Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) candidate decreased by 2.7-fold against the Delta plus variant, and levels dropped 3.3-fold for Moderna Inc's (NASDAQ: MRNA) candidate.",
    "url": "https://www.benzinga.com/general/biotech/21/07/22087492/johnson-johnsons-covid-19-shot-is-less-effective-against-delta-variant-study",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T13:58:12-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 14:27:01",
    "publisher": "Market Watch",
    "title": "J&J to stop selling opioids for 10 years and will pay $5 billion as part of settlement",
    "image": "https://images.financialmodelingprep.com/news/jj-to-stop-selling-opioids-for-10-years-and-20210721.jpg",
    "site": "marketwatch.com",
    "text": "Shares of Johnson & Johnson were up 0.3% in trading on Wednesday after a dozen or so state attorneys general announced an opioid settlement that requires J&J to pay $5 billion over nine years, including $3.7 billion in payments over the first three years. The company is also required to stop selling opioids for 10 years, and it cannot fund or provide grants to organizations that promote opioids or lobby on opioids during that time period.",
    "url": "https://www.marketwatch.com/story/jj-to-stop-selling-opioids-for-10-years-and-will-pay-5-billion-as-part-of-settlement-2021-07-21",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T14:27:01-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 15:32:28",
    "publisher": "Forbes",
    "title": "J&J And Other Drug Companies Strike $26 Billion Opioid Settlement With States",
    "image": "https://images.financialmodelingprep.com/news/jj-and-other-drug-companies-strike-26-billion-opioid-20210721.jpg",
    "site": "forbes.com",
    "text": "The deal will resolve thousands of opioid crisis-related lawsuits.",
    "url": "https://www.forbes.com/sites/carlieporterfield/2021/07/21/jj-and-other-drug-companies-strike-26-billion-opioid-settlement-with-states/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T15:32:28-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 16:44:00",
    "publisher": "The Motley Fool",
    "title": "Dow Jones Up 270 Points After Coca-Cola, Johnson & Johnson, Verizon Announce Earnings",
    "image": "https://images.financialmodelingprep.com/news/dow-jones-up-270-points-after-cocacola-johnson-johnson-20210721.jpg",
    "site": "fool.com",
    "text": "A modest day of gains after the three stalwarts reported results that met investor expectations.",
    "url": "https://www.fool.com/investing/2021/07/21/dow-jones-up-270-points-after-coca-cola-johnson-jo/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T16:44:00-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 16:47:49",
    "publisher": "InvestorPlace",
    "title": "What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.",
    "image": "https://images.financialmodelingprep.com/news/what-did-the-stock-market-do-today-3-big-20210721.jpg",
    "site": "investorplace.com",
    "text": "What did the stock market do today? It began to address the opioid crisis, it tuned in on Bitcoin and it saw a devastating Olympics loss.",
    "url": "https://investorplace.com/2021/07/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-10/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T16:47:49-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 17:43:35",
    "publisher": "InvestorPlace",
    "title": "4 Top Stock Trades for Thursday: SQ, JNJ, KO, CMG",
    "image": "https://images.financialmodelingprep.com/news/4-top-stock-trades-for-thursday-sq-jnj-ko-20210721.jpg",
    "site": "investorplace.com",
    "text": "Square, Johnson & Johnson, Coca-Cola and Chipotle Mexican Grill were our top stock trades for Thursday. Now, let's look at the charts.",
    "url": "https://investorplace.com/2021/07/4-top-stock-trades-for-thursday-sq-jnj-ko-cmg/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T17:43:35-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-21 17:54:38",
    "publisher": "New York Post",
    "title": "Big 3 drug distributors, J&J reach landmark $26B opioid settlement",
    "image": "https://images.financialmodelingprep.com/news/big-3-drug-distributors-jj-reach-landmark-26b-opioid-20210721.jpg",
    "site": "nypost.com",
    "text": "A group of state attorneys general unveiled on Wednesday a landmark, $26 billion settlement resolving claims that the three largest US drug distributors and drugmaker Johnson & Johnson helped fuel a deadly nationwide opioid epidemic. Under the settlement proposal, distributors McKesson, Cardinal Health and AmerisourceBergen are expected to pay a combined $21 billion, while Johnson.",
    "url": "https://nypost.com/2021/07/21/big-3-drug-distributors-jj-reach-landmark-26b-opioid-settlement/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-21T17:54:38-04:00",
    "date_et": "2021-07-21"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 00:43:57",
    "publisher": "Seeking Alpha",
    "title": "Johnson & Johnson: Nothing New, 7-8% Gains Per Year From Here",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-nothing-new-78-gains-per-year-from-20210722.jpeg",
    "site": "seekingalpha.com",
    "text": "Johnson & Johnson: Nothing New, 7-8% Gains Per Year From Here",
    "url": "https://seekingalpha.com/article/4440510-johnson-and-johnson-nothing-new-7-8-percent-gains-per-year-from-here",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T00:43:57-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 07:01:00",
    "publisher": "The Motley Fool",
    "title": "How Big of an Impact Will COVID-19 Have on the Stock Market Going Forward?",
    "image": "https://images.financialmodelingprep.com/news/how-big-of-an-impact-will-covid19-have-on-20210722.jpg",
    "site": "fool.com",
    "text": "Coronavirus variants will be the key variable.",
    "url": "https://www.fool.com/investing/2021/07/22/how-big-of-an-impact-will-covid-19-have-on-the-sto/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T07:01:00-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 08:34:45",
    "publisher": "Seeking Alpha",
    "title": "Pre-August Billionaire Flash: 63 Stocks, 41 Dividends, 3 Buys",
    "image": "https://images.financialmodelingprep.com/news/preaugust-billionaire-flash-63-stocks-41-dividends-3-buys-20210722.jpg",
    "site": "seekingalpha.com",
    "text": "Kiplinger Investing publishes opportune buy-lists for investors online. Two billionaire stock-lists by Dan Burrows included 50 published 12/8/20, with 30 more out June 1, 2021. Seventeen were duplicated, leaving 63. 41 of these 63 billionaire-held stocks pay dividends. As of 7/20/21, the top-ten ranged 2.52%-6.22% by annual yield and ranged 23.13%-52.70% per broker-estimated price-target upsides.",
    "url": "https://seekingalpha.com/article/4440565-pre-august-billionaire-flash-63-stocks-41-dividends-3-buys",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T08:34:45-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 10:42:29",
    "publisher": "Zacks Investment Research",
    "title": "US States Get $26B Settlement Deal in Opioid Abuse Litigation",
    "image": "https://images.financialmodelingprep.com/news/us-states-get-26b-settlement-deal-in-opioid-abuse-20210722.jpg",
    "site": "zacks.com",
    "text": "Attorney generals of several states reach settlement deal with J&J (JNJ) and three drug distributors - MCK, CAH and ABC - related to thousands of opioid abuse litigations. Non-participating states may join the deal soon.",
    "url": "https://www.zacks.com/stock/news/1765876/us-states-get-26b-settlement-deal-in-opioid-abuse-litigation",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T10:42:29-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 11:28:13",
    "publisher": "Zacks Investment Research",
    "title": "JNJ Beats on Q2 Earnings, Ups View: ETFs to Buy",
    "image": "https://images.financialmodelingprep.com/news/jnj-beats-on-q2-earnings-ups-view-etfs-to-buy-20210722.jpg",
    "site": "zacks.com",
    "text": "The company recorded 164 million in COVID-19 vaccine sales in the second quarter, up 64% from the first, and aims to fetch $2.5 billion in sales by the end of the year.",
    "url": "https://www.zacks.com/stock/news/1765847/jnj-beats-on-q2-earnings-ups-view-etfs-to-buy",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T11:28:13-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 11:30:00",
    "publisher": "The Motley Fool",
    "title": "Here's How to Find the Best Dividend Stocks",
    "image": "https://images.financialmodelingprep.com/news/heres-how-to-find-the-best-dividend-stocks-20210722.jpg",
    "site": "fool.com",
    "text": "Examining key financial figures can help you pick companies that are likely to keep distributing those steady payments.",
    "url": "https://www.fool.com/investing/2021/07/22/heres-how-to-find-the-best-dividend-stocks/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T11:30:00-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-22 13:25:40",
    "publisher": "Benzinga",
    "title": "European Medicine Agency Lists Guillain-Barré Syndrome As Rare Side Effect For JNJ COVID-19 Vaccine",
    "image": "https://images.financialmodelingprep.com/news/european-medicine-agency-lists-guillainbarr-syndrome-as-rare-side-20210722.jpeg",
    "site": "benzinga.com",
    "text": "Guillain-Barre syndrome (GBS) will be listed as a very rare side effect of Johnson & Johnson's (NYSE: JNJ) COVID-19 Vaccine. The warning will be included in the product information to raise awareness among healthcare professionals and people taking the vaccine, the EMA said in a statement.",
    "url": "https://www.benzinga.com/general/biotech/21/07/22108099/european-medicine-agency-lists-guillain-barr-syndrome-as-rare-side-effect-for-jnj-covid-19-vaccin",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-22T13:25:40-04:00",
    "date_et": "2021-07-22"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-23 06:00:00",
    "publisher": "The Motley Fool",
    "title": "Can Today's Vaccines Beat the Delta Variant?",
    "image": "https://images.financialmodelingprep.com/news/can-todays-vaccines-beat-the-delta-variant-20210723.jpg",
    "site": "fool.com",
    "text": "Moderna, Pfizer, and Johnson & Johnson are optimistic.",
    "url": "https://www.fool.com/investing/2021/07/23/can-todays-vaccines-beat-the-delta-variant/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-23T06:00:00-04:00",
    "date_et": "2021-07-23"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-23 06:12:00",
    "publisher": "The Motley Fool",
    "title": "The Big Winner With Johnson & Johnson's Recent FDA Approval",
    "image": "https://images.financialmodelingprep.com/news/the-big-winner-with-johnson-johnsons-recent-fda-approval-20210723.jpg",
    "site": "fool.com",
    "text": "J&J's smaller partner could benefit in a big way from the approval of a new version of blood cancer drug Darzalex.",
    "url": "https://www.fool.com/investing/2021/07/23/the-big-winner-with-johnson-johnsons-recent-fda-ap/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-23T06:12:00-04:00",
    "date_et": "2021-07-23"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-23 11:01:34",
    "publisher": "Benzinga",
    "title": "Earnings Outlook For J&J Snack Foods",
    "image": "https://images.financialmodelingprep.com/news/earnings-outlook-for-jj-snack-foods-20210723.jpg",
    "site": "benzinga.com",
    "text": "On Monday, July 26, J&J Snack Foods (NASDAQ:JJSF) will release its latest earnings report. Decipher the announcement with Benzinga's help.",
    "url": "https://www.benzinga.com/news/earnings/21/07/22125240/earnings-outlook-for-j-j-snack-foods",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-23T11:01:34-04:00",
    "date_et": "2021-07-23"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-23 14:08:42",
    "publisher": "Schaeffers Research",
    "title": "Stocks Headed for Weekly Wins Despite Monday's Rout",
    "image": "https://images.financialmodelingprep.com/news/stocks-headed-for-weekly-wins-despite-mondays-rout-20210723.jpg",
    "site": "schaeffersresearch.com",
    "text": "It was a jarring start to the week for Wall Street, with stocks in a seeming freefall as a rise in global Covid-19 cases, specifically the delta variant, had many wondering if the smooth economic recovery expected might be too good to be true.",
    "url": "https://www.schaeffersresearch.com/content/news/2021/07/23/stocks-headed-for-weekly-wins-despite-mondays-rout",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-23T14:08:42-04:00",
    "date_et": "2021-07-23"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-24 12:19:30",
    "publisher": "Invezz",
    "title": "Is August a good month for buying Johnson & Johnson shares?",
    "image": "https://images.financialmodelingprep.com/news/is-august-a-good-month-for-buying-johnson-johnson-20210724.jpg",
    "site": "invezz.com",
    "text": "Johnson & Johnson (NYSE: JNJ) shares have advanced almost 5% since the beginning of July 2021; the company reported better than expected second-quarter results this Wednesday and expects even better trends in the third quarter. Fundamental analysis: Johnson & Johnson raised its outlook for the fiscal 2021 year The company's business has proven improvements throughout […] The post Is August a good month for buying Johnson & Johnson shares?",
    "url": "https://invezz.com/news/2021/07/24/is-august-a-good-month-for-buying-johnson-johnson-shares/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-24T12:19:30-04:00",
    "date_et": "2021-07-24"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-25 06:15:00",
    "publisher": "The Motley Fool",
    "title": "3 Great Investments for the Next Market Crash",
    "image": "https://images.financialmodelingprep.com/news/3-great-investments-for-the-next-market-crash-20210725.jpg",
    "site": "fool.com",
    "text": "These investments will spare you pain during the next market crash.",
    "url": "https://www.fool.com/investing/2021/07/25/3-great-investments-for-the-next-market-crash/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-25T06:15:00-04:00",
    "date_et": "2021-07-25"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-26 06:00:41",
    "publisher": "InvestorPlace",
    "title": "3 Blue-Chip Dividend Stocks for a Bear Market",
    "image": "https://images.financialmodelingprep.com/news/3-bluechip-dividend-stocks-for-a-bear-market-20210726.jpg",
    "site": "investorplace.com",
    "text": "If profit taking leads to further market declines, then investors may want to brace for further volatility with dividend stocks. The post 3 Blue-Chip Dividend Stocks for a Bear Market appeared first on InvestorPlace.",
    "url": "https://investorplace.com/2021/07/3-blue-chip-dividend-stocks-for-a-bear-market/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-26T06:00:41-04:00",
    "date_et": "2021-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-26 14:35:36",
    "publisher": "Investopedia",
    "title": "Johnson & Johnson (JNJ) Option Traders Aim to Continue Positive Trend",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-jnj-option-traders-aim-to-continue-positive-20210726.jpg",
    "site": "investopedia.com",
    "text": "The price action has tested resistance, while the option activity suggests that traders continue to both buy calls and sell puts.",
    "url": "https://www.investopedia.com/jnj-option-traders-aim-to-continue-positive-trend-5193976",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-26T14:35:36-04:00",
    "date_et": "2021-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-26 18:23:04",
    "publisher": "Zacks Investment Research",
    "title": "J&J Snack Foods (JJSF) Surpasses Q3 Earnings and Revenue Estimates",
    "image": "https://images.financialmodelingprep.com/news/jj-snack-foods-jjsf-surpasses-q3-earnings-and-revenue-20210726.jpg",
    "site": "zacks.com",
    "text": "J&J Snack Foods (JJSF) delivered earnings and revenue surprises of 91.14% and 3.57%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://www.zacks.com/stock/news/1767918/j-j-snack-foods-jjsf-surpasses-q3-earnings-and-revenue-estimates",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-26T18:23:04-04:00",
    "date_et": "2021-07-26"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-27 05:55:00",
    "publisher": "The Motley Fool",
    "title": "Worries About the Delta Variant Could Be Overdone Based on Clues From These Healthcare Giants",
    "image": "https://images.financialmodelingprep.com/news/worries-about-the-delta-variant-could-be-overdone-based-20210727.jpg",
    "site": "fool.com",
    "text": "What healthcare executives are saying so far about the impact of the coronavirus variant on their businesses is reassuring.",
    "url": "https://www.fool.com/investing/2021/07/27/worries-about-the-delta-variant-could-be-overdone/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-27T05:55:00-04:00",
    "date_et": "2021-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-27 13:12:07",
    "publisher": "Seeking Alpha",
    "title": "J&J Snack Foods Corp. (JJSF) CEO Daniel Fachner on Q3 2021 Results - Earnings Call Transcript",
    "image": "https://images.financialmodelingprep.com/news/jj-snack-foods-corp-jjsf-ceo-daniel-fachner-on-q3-20210727.jpg",
    "site": "seekingalpha.com",
    "text": "J&J Snack Foods Corp. (JJSF) CEO Daniel Fachner on Q3 2021 Results - Earnings Call Transcript",
    "url": "https://seekingalpha.com/article/4441713-j-and-j-snack-foods-corp-jjsf-ceo-daniel-fachner-on-q3-2021-results-earnings-call-transcript",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-27T13:12:07-04:00",
    "date_et": "2021-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-27 14:29:03",
    "publisher": "Benzinga",
    "title": "Pharma Heavyweights, Including Pfizer And JNJ Trying To Push Global Tax Deal Amid COVID-19 Role: WSJ",
    "image": "https://images.financialmodelingprep.com/news/pharma-heavyweights-including-pfizer-and-jnj-trying-to-push-global-20210727.jpg",
    "site": "benzinga.com",
    "text": "In the face of a comprehensive global tax agreement intended to inhibit tax avoidance opportunities, industry executives and lobbyists are mounting a quiet campaign to push back against the measure, the Wall Street Journal reports.  This time, the pharma industry is using the goodwill garnered by the rapid deployment of COVID-19 vaccines as the new negotiating tool.",
    "url": "https://www.benzinga.com/general/biotech/21/07/22178862/pharma-heavyweights-including-pfizer-and-jnj-trying-to-push-global-tax-deal-amid-covid-19-role-ws",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-27T14:29:03-04:00",
    "date_et": "2021-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-27 16:10:00",
    "publisher": "PRNewsWire",
    "title": "Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-to-participate-in-the-virtual-wells-fargo-20210727.jpg",
    "site": "prnewswire.com",
    "text": "NEW BRUNSWICK, N.J., July 27, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the Virtual Wells Fargo Healthcare Conference on Friday, September 10 th.",
    "url": "https://www.prnewswire.com/news-releases/johnson--johnson-to-participate-in-the-virtual-wells-fargo-healthcare-conference-301342552.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-27T16:10:00-04:00",
    "date_et": "2021-07-27"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-28 11:29:35",
    "publisher": "CNN",
    "title": "Advocacy group sues Johnson & Johnson over cancer-linked powder products marketed to Black women",
    "image": "https://images.financialmodelingprep.com/news/advocacy-group-sues-johnson-johnson-over-cancerlinked-powder-products-20210728.jpg",
    "site": "cnn.com",
    "text": "A Black women's advocacy group filed a lawsuit Tuesday accusing Johnson & Johnson of selectively marketing the company's talcum-based products, including Johnson's Baby Powder, to African-American women despite knowing for years that the items had been linked to ovarian cancer, an allegation J&J denies.",
    "url": "https://www.cnn.com/2021/07/28/business/johnson--johnson-talc-lawsuit-black-women/index.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-28T11:29:35-04:00",
    "date_et": "2021-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-28 12:20:40",
    "publisher": "Investopedia",
    "title": "Mega Caps Could Lead the S&P 500 Higher",
    "image": "https://images.financialmodelingprep.com/news/mega-caps-could-lead-the-sp-500-higher-20210728.jpg",
    "site": "investopedia.com",
    "text": "The S&P 500 recently notched all-time highs. Well-defined risk/reward setups suggest that these mega caps will be the focus of the next leg higher.",
    "url": "https://www.investopedia.com/mega-caps-could-lead-the-s-and-p-500-higher-5194508",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-28T12:20:40-04:00",
    "date_et": "2021-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-28 12:55:12",
    "publisher": "Zacks Investment Research",
    "title": "Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now",
    "image": "https://images.financialmodelingprep.com/news/why-johnson-johnson-jnj-is-a-great-dividend-stock-20210728.jpg",
    "site": "zacks.com",
    "text": "Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?",
    "url": "https://www.zacks.com/stock/news/1769465/why-johnson-johnson-jnj-is-a-great-dividend-stock-right-now",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-28T12:55:12-04:00",
    "date_et": "2021-07-28"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-29 01:02:26",
    "publisher": "Forbes",
    "title": "FDA Extends Shelf Life Of Johnson & Johnson Covid-19 Vaccine To Six Months",
    "image": "https://images.financialmodelingprep.com/news/fda-extends-shelf-life-of-johnson-johnson-covid19-vaccine-20210729.jpg",
    "site": "forbes.com",
    "text": "The extension will give health workers six additional weeks to administer millions of doses of the single-shot vaccine.",
    "url": "https://www.forbes.com/sites/siladityaray/2021/07/29/fda-extends-shelf-life-of-johnson--johnson-covid-19-vaccine-to-six-months/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-29T01:02:26-04:00",
    "date_et": "2021-07-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-29 06:09:00",
    "publisher": "The Motley Fool",
    "title": "Wall Street Might Be Missing This Key to Growth at Johnson & Johnson",
    "image": "https://images.financialmodelingprep.com/news/wall-street-might-be-missing-this-key-to-growth-20210729.jpeg",
    "site": "fool.com",
    "text": "Shareholders bored by lagging returns might get some excitement in the near future.",
    "url": "https://www.fool.com/investing/2021/07/29/wall-street-missing-key-growth-johnson-johnson/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-29T06:09:00-04:00",
    "date_et": "2021-07-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-29 06:32:00",
    "publisher": "The Motley Fool",
    "title": "3 Dividend Stocks Safe Enough to Bet the Farm On",
    "image": "https://images.financialmodelingprep.com/news/3-dividend-stocks-safe-enough-to-bet-the-farm-20210729.jpg",
    "site": "fool.com",
    "text": "You shouldn't invest your life savings into any one stock, but these three have some serious potential.",
    "url": "https://www.fool.com/investing/2021/07/29/3-dividend-stocks-safe-enough-to-bet-the-farm-on/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-29T06:32:00-04:00",
    "date_et": "2021-07-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-29 07:32:00",
    "publisher": "The Motley Fool",
    "title": "Are Johnson & Johnson's Legal Troubles Enough of a Reason to Avoid the Stock?",
    "image": "https://images.financialmodelingprep.com/news/are-johnson-johnsons-legal-troubles-enough-of-a-reason-20210729.jpeg",
    "site": "fool.com",
    "text": "Investors should consider more than just the healthcare giant's impressive financial numbers when deciding whether to invest in its stock over the long term.",
    "url": "https://www.fool.com/investing/2021/07/29/are-johnson-johnsons-legal-troubles-enough-of-a-re/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-29T07:32:00-04:00",
    "date_et": "2021-07-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-29 11:14:00",
    "publisher": "PRNewsWire",
    "title": "Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney",
    "image": "https://images.financialmodelingprep.com/news/women-cancer-victims-opposed-to-johnson-johnsons-texas-twostep-20210729.jpg",
    "site": "prnewswire.com",
    "text": "WASHINGTON, July 29, 2021 /PRNewswire/ -- More than 30,000 women cancer victims would retain their constitutional right to have juries decide if talc in Johnson & Johnson's (NYSE:JNJ) baby products caused their ovarian cancer under bankruptcy reforms proposed Wednesday by key lawmakers in the U.S. Senate and House of Representatives. The Nondebtor Release Prohibition Act of 2021 would close controversial bankruptcy loopholes, including non-consensual third-party releases and the so-called \"Texas Two-Step.",
    "url": "https://www.prnewswire.com/news-releases/women-cancer-victims-opposed-to-johnson--johnsons-texas-two-step-bankruptcy-ploy-urge-passage-of-reforms-introduced-by-warren-durbin-nadler-blumenthal-and-maloney-301344451.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-29T11:14:00-04:00",
    "date_et": "2021-07-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-29 13:57:11",
    "publisher": "Benzinga",
    "title": "US House Panel Asks JNJ For Documents Over Talc Liabilities Bankruptcy Plan",
    "image": "https://images.financialmodelingprep.com/news/us-house-panel-asks-jnj-for-documents-over-talc-20210729.jpg",
    "site": "benzinga.com",
    "text": "A House Oversight subcommittee sent a letter to Johnson & Johnson's (NYSE: JNJ) CEO Alex Gorsky asking for documents and information on any company plans to place a subsidiary into bankruptcy over talc liabilities, Reuters reported. Democrat Raja Krishnamoorthi, chairman of the U.S. House of Representatives Committee on Oversight and Reform's subcommittee on economic and consumer policy, wrote that the panel is trying to learn how J&J's plans may affect people who have said the company's baby powder harmed them.",
    "url": "https://www.benzinga.com/general/biotech/21/07/22229037/us-house-panel-asks-jnj-for-documents-over-talc-liabilities-bankruptcy-plan",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-29T13:57:11-04:00",
    "date_et": "2021-07-29"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-30 09:08:20",
    "publisher": "Zacks Investment Research",
    "title": "Pharma & Healthcare ETFs at a One-Year High: Here's Why",
    "image": "https://images.financialmodelingprep.com/news/pharma-healthcare-etfs-at-a-oneyear-high-heres-why-20210730.jpg",
    "site": "zacks.com",
    "text": "Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.",
    "url": "https://www.zacks.com/stock/news/1771441/pharma-healthcare-etfs-at-a-one-year-high-here-s-why",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-30T09:08:20-04:00",
    "date_et": "2021-07-30"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-07-31 06:05:00",
    "publisher": "The Motley Fool",
    "title": "4 of the Safest Dividend Stocks That'll Help You Crush Inflation",
    "image": "https://images.financialmodelingprep.com/news/4-of-the-safest-dividend-stocks-thatll-help-you-20210731.jpg",
    "site": "fool.com",
    "text": "Between hearty yields and share price appreciation, these stocks can put inflation in its place.",
    "url": "https://www.fool.com/investing/2021/07/31/4-safest-dividend-stocks-help-you-crush-inflation/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-07-31T06:05:00-04:00",
    "date_et": "2021-07-31"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-08-02 07:47:31",
    "publisher": "Benzinga",
    "title": "Johnson & Johnson Pulls Application For Accelerated Approval Of COVID-19 Shot In India: Report",
    "image": "https://images.financialmodelingprep.com/news/johnson-johnson-pulls-application-for-accelerated-approval-of-covid19-20210802.jpg",
    "site": "benzinga.com",
    "text": "Johnson & Johnson (NYSE: JNJ) has withdrawn its application seeking accelerated approval of its COVID-19 vaccine, drugs regulator Drugs Controller General of India informed.  It is yet to be clear the reason for the withdrawal of the application.",
    "url": "https://www.benzinga.com/general/biotech/21/08/22270727/johnson-johnson-pulls-application-for-accelerated-approval-of-covid-19-shot-in-india-report",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-08-02T07:47:31-04:00",
    "date_et": "2021-08-02"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-08-03 07:22:00",
    "publisher": "The Motley Fool",
    "title": "How the Delta Variant Could Change the World of Coronavirus Vaccine Stocks",
    "image": "https://images.financialmodelingprep.com/news/how-the-delta-variant-could-change-the-world-of-20210803.jpg",
    "site": "fool.com",
    "text": "It'll push the winners further ahead of the laggards.",
    "url": "https://www.fool.com/investing/2021/08/03/how-the-delta-variant-could-change-the-world-of-co/",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-08-03T07:22:00-04:00",
    "date_et": "2021-08-03"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-08-03 14:01:06",
    "publisher": "Seeking Alpha",
    "title": "The Highest Quality Dividend Growth Stocks",
    "image": "https://images.financialmodelingprep.com/news/the-highest-quality-dividend-growth-stocks-20210803.jpg",
    "site": "seekingalpha.com",
    "text": "This article updates one published by David Van Knapp in June 2020.",
    "url": "https://seekingalpha.com/article/4444407-the-highest-quality-dividend-growth-stocks",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-08-03T14:01:06-04:00",
    "date_et": "2021-08-03"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-08-03 17:37:16",
    "publisher": "CNBC",
    "title": "J&J Covid vaccine recipients can get supplemental Pfizer or Moderna shots in San Francisco",
    "image": "https://images.financialmodelingprep.com/news/jj-covid-vaccine-recipients-can-get-supplemental-pfizer-or-moderna-20210803.jpeg",
    "site": "cnbc.com",
    "text": "J&J recipients can make special requests to get a \"supplemental dose\" of an mRNA vaccine, San Francisco health officials said in a statement to CNBC.",
    "url": "https://www.cnbc.com/2021/08/03/jj-covid-vaccine-recipients-can-get-supplemental-pfizer-or-moderna-shots-in-san-francisco.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-08-03T17:37:16-04:00",
    "date_et": "2021-08-03"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-08-04 12:13:19",
    "publisher": "Zacks Investment Research",
    "title": "Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMN",
    "image": "https://images.financialmodelingprep.com/news/drugbiotech-stocks-q2-earnings-due-on-aug-5-regn-20210804.jpg",
    "site": "zacks.com",
    "text": "Let us take a look at what is in store for some of the drug/biotech stocks, which are scheduled to report on Aug 5.",
    "url": "https://www.zacks.com/stock/news/1774399/drug-biotech-stocks-q2-earnings-due-on-aug-5-regn-mrna-zts-ilmn",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-08-04T12:13:19-04:00",
    "date_et": "2021-08-04"
  },
  {
    "symbol": "JNJ",
    "publishedDate": "2021-08-04 17:23:07",
    "publisher": "CNBC",
    "title": "CVS Health stops offering J&J Covid vaccine at its pharmacies, available at select MinuteClinics",
    "image": "https://images.financialmodelingprep.com/news/cvs-health-stops-offering-jj-covid-vaccine-at-its-pharmacies-20210804.jpeg",
    "site": "cnbc.com",
    "text": "CVS Health has stopped offering J&J's single-dose Covid-19 in its pharmacies but will continue to make the shots available at certain MinuteClinic locations.",
    "url": "https://www.cnbc.com/2021/08/04/cvs-health-stops-offering-jj-covid-vaccine-at-its-pharmacies-available-at-select-minuteclinics.html",
    "ticker": "JNJ",
    "event_date": "2021-07-21",
    "window_start": "2021-07-07",
    "window_end": "2021-08-04",
    "publishedDateET": "2021-08-04T17:23:07-04:00",
    "date_et": "2021-08-04"
  }
]